Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab

Clin Lung Cancer. 2020 Nov;21(6):e547-e550. doi: 10.1016/j.cllc.2020.05.027. Epub 2020 Jun 2.
No abstract available

Keywords: COVID-19; Coronavirus; Immunotherapy; NSCLC; PD-L1 inhibitors; Radiotherapy.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antineoplastic Agents, Immunological / administration & dosage
  • COVID-19
  • COVID-19 Testing
  • Chemoradiotherapy / methods
  • Clinical Laboratory Techniques*
  • Coronavirus Infections / diagnosis*
  • Diagnosis, Differential
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / therapy*
  • Male
  • Neoplasm Staging
  • Pandemics
  • Pneumonia, Viral / diagnosis*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological
  • durvalumab